Novel strategies for treating sepsis include drotrecogin alfa (activated), tight glycemic control, EGDT, and low-dose corticosteroids. Further research is needed to answer questions surrounding ...

The optimization of hemodynamic endpoints in critically ill patients has been the subject of many investigations; studies with both negative and positive outcomes have been reported. [32] Among ...